Early or deferred initiation of efavirenz during rifampicin‐based TB therapy has no significant effect on CYP3A induction in TB‐HIV infected patients-Reference-Cited by-同舟云学术

Early or deferred initiation of efavirenz during rifampicin‐based TB therapy has no significant effect on CYP3A induction in TB‐HIV infected patients

Published:2020-12-07 Issue:16 Volume:178 Page:3294-3308
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Aklillu Eleni¹^ORCID,Zumla Alimuddin²³,Habtewold Abiy⁴,Amogne Wondwossen⁵,Makonnen Eyasu⁶,Yimer Getnet⁶,Burhenne Jürgen⁷,Diczfalusy Ulf⁸

Affiliation:

1. Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital Huddinge C1:68 Karolinska Institutet Stockholm Sweden

2. Division of Infection and Immunity University College London, NIHR Biomedical Research Centre at UCL Hospitals NHS Foundation Trust London UK

3. UNZA‐UCLMS Research and Training Program, Department of Medicine University Teaching Hospital Lusaka Zambia

4. Department of Pharmaceutical Sciences, School of Pharmacy William Carey University Biloxi MS USA

5. Department of Internal Medicine, College of Health Science Addis Ababa University Addis Ababa Ethiopia

6. Department of Pharmacology, College of Health Sciences Addis Ababa University Addis Ababa Ethiopia

7. Department of Clinical Pharmacology and Pharmacoepidemiology University of Heidelberg Heidelberg Germany

8. Division of Clinical Chemistry, Department of Laboratory Medicine Karolinska Institutet at Karolinska University Hospital Stockholm Sweden

Funder

European and Developing Countries Clinical Trials Partnership

Vetenskapsrådet

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15309

Reference62 articles.

1. The Effect of Early Initiation of Antiretroviral Therapy in TB/HIV-Coinfected Patients

2. Integration of Antiretroviral Therapy with Tuberculosis Treatment

3. SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision Medicine

4. Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method

5. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear hormone receptors

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Pharmacogenomics Studies for Precision Medicine Among Ethiopian Patients and Their Clinical Implications: A Scoping Review;Pharmacogenomics and Personalized Medicine;2024-07

2. Variability in plasma rifampicin concentrations and role of SLCO1B1 , ABCB1 , AADAC2 and CES2 genotypes in Ethiopian patients with tuberculosis;Infectious Diseases;2024-02-05

3. Genetic and non‐genetic factors influencing efavirenz population pharmacokinetics among human immunodeficiency virus‐1‐infected children in Ethiopia;CPT: Pharmacometrics & Systems Pharmacology;2023-03-23

4. Clinical predictors of efavirenz-based regimen treatment durability: A two-year case-control study of antiretroviral-naïve patients;Journal of Infection and Public Health;2023-01

5. Pregnancy Increases CYP3A Enzymes Activity as Measured by the 4β-Hydroxycholesterol/Cholesterol Ratio;International Journal of Molecular Sciences;2022-12-02